ArticleFrontiers in medicine2026
Effects of fractional laser combined with amorolfine hydrochloride cream on fungal clearance rate and nursing outcomes in patients with onychomycosis: a retrospective clinical study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: To investigate the clinical efficacy, fungal clearance rate, and impact on quality of life of fractional laser combined with amorolfine hydrochloride cream in the treatment of onychomycosis. Methods: This study retrospectively analyzed 90 patients diagnosed with onychomycosis who were admitted to our hospital between November 2023 and November 2024. According to the treatment strategies received during routine clinical practice, patients were assigned to either the conventional group or the study group, with 45 cases in each group. The conventional group received amorolfine hydrochloride cream alone combined with routine nursing care, whereas the study group additionally received fractional laser therapy and targeted comprehensive nursing intervention on this basis. Comparative analyses were conducted between the two groups with respect to the fungal clearance rate, overall clinical intervention efficacy, quality-of-life scores before and after the intervention, incidence of adverse events, and nursing satisfaction. Results: After the intervention, the overall clinical effective rate and fungal clearance rate in the study group (95.56 ± 3.5, 95.56 ± 3.2%) were both significantly higher than those in the conventional group (82.22 ± 4.2, 77.78 ± 4.9%) ( Conclusion: Compared with amorolfine hydrochloride cream alone, fractional laser combined with amorolfine hydrochloride cream is safer and more effective in the treatment of onychomycosis, improves nursing outcomes, increases the fungal clearance rate, enhances quality of life, and reduces adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.